EFG Asset Management Americas Corp. Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

EFG Asset Management Americas Corp. lowered its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,829 shares of the healthcare conglomerate’s stock after selling 338 shares during the period. UnitedHealth Group accounts for about 3.5% of EFG Asset Management Americas Corp.’s holdings, making the stock its 4th biggest position. EFG Asset Management Americas Corp.’s holdings in UnitedHealth Group were worth $14,845,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock valued at $41,119,347,000 after purchasing an additional 1,147,051 shares in the last quarter. State Street Corp lifted its holdings in shares of UnitedHealth Group by 1.6% in the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock valued at $23,598,745,000 after purchasing an additional 714,903 shares in the last quarter. Capital World Investors lifted its holdings in shares of UnitedHealth Group by 2.8% in the first quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock valued at $17,750,351,000 after purchasing an additional 935,552 shares in the last quarter. Capital International Investors increased its position in shares of UnitedHealth Group by 4.3% during the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after acquiring an additional 790,219 shares during the last quarter. Finally, Capital Research Global Investors increased its position in shares of UnitedHealth Group by 8.3% during the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after acquiring an additional 1,482,338 shares during the last quarter. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $517.46 on Friday. The stock has a market cap of $484.02 billion, a P/E ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average price is $530.11 and its two-hundred day moving average price is $512.45. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The firm had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter last year, the company posted $4.70 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were given a dividend of $1.65 per share. The ex-dividend date was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.46%.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. Insiders sold 139,051 shares of company stock worth $74,450,958 in the last quarter. 0.40% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts recently commented on the company. Credit Suisse Group increased their price target on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research report on Thursday, September 8th. Morgan Stanley raised their target price on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Oppenheimer raised their target price on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Finally, SVB Leerink raised their target price on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $586.40.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.